CL2016002655A1 - Pharmaceutical composition for the treatment of pain-related allopathies, using as active agent ketorolac tromethamine and tramadol hydrochloride - Google Patents

Pharmaceutical composition for the treatment of pain-related allopathies, using as active agent ketorolac tromethamine and tramadol hydrochloride

Info

Publication number
CL2016002655A1
CL2016002655A1 CL2016002655A CL2016002655A CL2016002655A1 CL 2016002655 A1 CL2016002655 A1 CL 2016002655A1 CL 2016002655 A CL2016002655 A CL 2016002655A CL 2016002655 A CL2016002655 A CL 2016002655A CL 2016002655 A1 CL2016002655 A1 CL 2016002655A1
Authority
CL
Chile
Prior art keywords
pain
treatment
pharmaceutical composition
allopathies
active agent
Prior art date
Application number
CL2016002655A
Other languages
Spanish (es)
Inventor
Flores Oliver Daniel Walls
Hernández Ramón Rodríguez
Hernández Eduardo Barrena
Original Assignee
Laboratorios Liomont S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54359444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2016002655(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Liomont S A De C V filed Critical Laboratorios Liomont S A De C V
Publication of CL2016002655A1 publication Critical patent/CL2016002655A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

<p>COMPOSICION FARMACEUTICA PARA EL TRATAMIENTO DE ALOPATIAS RELACIONADAS CON EL DOLOR DE MODERADO A SEVERO, ANALGESICO, ANTIINFLAMATORIO, FIEBRE O ANTIPIRETICO, ENTRE OTROS, QUE UTILIZA COMO AGENTES ACTIVOS AL KETOROLACO TROMETAMINA Y CLORHIDRATO DE TRAMADOL EN UNA FORMA FARMACEUTICA INYECYABLE.</p><p> PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALOPATHY RELATED TO THE PAIN OF MODERATE TO SEVERE, ANALGESIC, ANTI-INFLAMMATORY, FEVER OR ANTIPIRETIC, BETWEEN OTHERS, WHICH USES AS ACTIVE AGENTS TO KETOROLACOR TORMETHYMATE INHIRMATMATIMATE INHIBITION INTO p>

CL2016002655A 2014-04-29 2016-10-19 Pharmaceutical composition for the treatment of pain-related allopathies, using as active agent ketorolac tromethamine and tramadol hydrochloride CL2016002655A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2014005152A MX2014005152A (en) 2014-04-29 2014-04-29 Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient.

Publications (1)

Publication Number Publication Date
CL2016002655A1 true CL2016002655A1 (en) 2017-02-17

Family

ID=54359444

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016002655A CL2016002655A1 (en) 2014-04-29 2016-10-19 Pharmaceutical composition for the treatment of pain-related allopathies, using as active agent ketorolac tromethamine and tramadol hydrochloride

Country Status (4)

Country Link
CL (1) CL2016002655A1 (en)
MX (1) MX2014005152A (en)
SV (1) SV2016005308A (en)
WO (1) WO2015166418A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018003456A (en) 2017-12-21 2019-09-06 Gruenenthal Gmbh Pharmaceutical combination in a bilayer tablet form comprising ketorolac tromethamine and tramadol hydrochloride, and its use in pain treatment.
MX2018000963A (en) 2018-01-22 2018-12-13 Federico Amezcua Amezcua Synergistic pharmaceutical composition originated from the active enantiomer s-ketorolac tromethamine and tramadol hydrochloride.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03012048A (en) * 2003-12-19 2005-06-23 Victor Guillermo Alvarez Ochoa Pharmaceutical composition in capsules comprising a non-steroidal anti-inflammatory and an opiate analgesic for handling pain.
MX2010011193A (en) * 2010-10-12 2012-04-18 World Trade Imp Exp Wtie Ag Liquid pharmaceutical composition for pain treatment and prevention.
WO2013163142A1 (en) * 2012-04-25 2013-10-31 Yung Shin Pharm. Ind. Co., Ltd. Liquid pharmaceutical formulation containing ketorolac and tramadol

Also Published As

Publication number Publication date
WO2015166418A3 (en) 2016-01-07
WO2015166418A2 (en) 2015-11-05
MX2014005152A (en) 2015-10-28
SV2016005308A (en) 2017-05-15

Similar Documents

Publication Publication Date Title
CR20200064A (en) Carboxamides as modulators of sodium channels
NI201600051A (en) COMBINATIONS OF HISTONE DESACETILASE INHIBITORS AND IMMUNOMODULATING DRUGS
SV2015005115A (en) DERIVATIVES OF PIRAZOLOPIRROLIDINE AND ITS USE IN THE TREATMENT OF DISEASES
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
CL2016001231A1 (en) Autotaxin Inhibitor Compounds
CO2017004525A2 (en) Ror-gamma inhibitory dihydropyrrolopyridines
DOP2016000298A (en) PIRAZOLOPIRIDINAS AND PIRAZOLOPIRIMIDINAS
CL2016002516A1 (en) &#34;Substituted spirocycle derived compounds, atx inhibitors; pharmaceutical composition comprising them; and its use in the treatment of cancer, inflammations, neuropathic pain, fibrotic diseases, thrombosis, among others ”. pct
EA201690223A1 (en) FACTOR INHIBITORS IN THE COMPLEMENT BASED ON PIPERIDININILINDOL DERIVATIVES AND THEIR APPLICATION
CL2012002317A1 (en) Compounds derived from thienopyrimidines, knase inhibitors mnk1 / mnk2; pharmaceutical composition; and its use for the treatment or prophylaxis of metabolic diseases, such as diabetes, kidney damage, cancer, inflammatory diseases, among others.
CL2015002733A1 (en) Pharmaceutical composition of s-ketamine hydrochloride.
HN2012000023A (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES
CL2016001918A1 (en) Heteroaryl amides as protein aggregation inhibitors
CL2017000845A1 (en) Lysine Gingipain Inhibitors
BR112015029894A2 (en) solid pharmaceutical dosage form
CU24434B1 (en) COMPOUNDS DERIVED FROM N- (1,5-DIMETHYL-3-OXO-2,3-DIHYDRO-1H-PIRAZOL-4-IL) -4-METHYL-5-ISOXAZOLE-3-CARBOXAMIDE ACTIVE AS SELECTIVE INHIBITORS OF SMURF-1
UY35328A (en) TREATMENT OF PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS WITH LAQUINIMOD
CL2016002655A1 (en) Pharmaceutical composition for the treatment of pain-related allopathies, using as active agent ketorolac tromethamine and tramadol hydrochloride
MX2019003039A (en) Extended relief dosage form.
CR20190145A (en) Indazole compounds for use in tendon and/or ligament injuries
SV2016005309A (en) PROCESS OF OBTAINING AND PHARMACEUTICAL COMPOSITION FOR KETOROLACO TROMETAMINE AND SUBLINGUAL TRAMADOL CHLORHYDRATE USED FOR PAIN
MX2013001279A (en) Pharmaceutical composition with a selective enzyme phosphodiesterase inhibitor in an oral gel form.
CO7170180A2 (en) Injectable pharmaceutical composition of dexketoprofen and tramadol
PE20170305A1 (en) SYNERGISTIC COMBINATION OF PARACETAMOL / CELECOXIB FOR THE TREATMENT OF INFLAMMATORY PAIN
CL2016002083A1 (en) Topical antifungal composition for the treatment of onychomycosis